rs592052

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_017614.5(BHMT2):​c.33+2654A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.405 in 152,070 control chromosomes in the GnomAD database, including 15,043 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 15043 hom., cov: 32)

Consequence

BHMT2
NM_017614.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.374

Publications

4 publications found
Variant links:
Genes affected
BHMT2 (HGNC:1048): (betaine--homocysteine S-methyltransferase 2) Homocysteine is a sulfur-containing amino acid that plays a crucial role in methylation reactions. Transfer of the methyl group from betaine to homocysteine creates methionine, which donates the methyl group to methylate DNA, proteins, lipids, and other intracellular metabolites. The protein encoded by this gene is one of two methyl transferases that can catalyze the transfer of the methyl group from betaine to homocysteine. Anomalies in homocysteine metabolism have been implicated in disorders ranging from vascular disease to neural tube birth defects such as spina bifida. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2010]
DMGDH (HGNC:24475): (dimethylglycine dehydrogenase) This gene encodes an enzyme involved in the catabolism of choline, catalyzing the oxidative demethylation of dimethylglycine to form sarcosine. The enzyme is found as a monomer in the mitochondrial matrix, and uses flavin adenine dinucleotide and folate as cofactors. Mutation in this gene causes dimethylglycine dehydrogenase deficiency, characterized by a fishlike body odor, chronic muscle fatigue, and elevated levels of the muscle form of creatine kinase in serum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
DMGDH Gene-Disease associations (from GenCC):
  • dimethylglycine dehydrogenase deficiency
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_017614.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.594 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017614.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BHMT2
NM_017614.5
MANE Select
c.33+2654A>G
intron
N/ANP_060084.2
BHMT2
NM_001178005.2
c.33+2654A>G
intron
N/ANP_001171476.1Q9H2M3-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BHMT2
ENST00000255192.8
TSL:1 MANE Select
c.33+2654A>G
intron
N/AENSP00000255192.3Q9H2M3-1
BHMT2
ENST00000896185.1
c.33+2654A>G
intron
N/AENSP00000566244.1
BHMT2
ENST00000896179.1
c.33+2654A>G
intron
N/AENSP00000566238.1

Frequencies

GnomAD3 genomes
AF:
0.405
AC:
61601
AN:
151952
Hom.:
15036
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.116
Gnomad AMI
AF:
0.693
Gnomad AMR
AF:
0.521
Gnomad ASJ
AF:
0.380
Gnomad EAS
AF:
0.612
Gnomad SAS
AF:
0.461
Gnomad FIN
AF:
0.573
Gnomad MID
AF:
0.456
Gnomad NFE
AF:
0.507
Gnomad OTH
AF:
0.432
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.405
AC:
61608
AN:
152070
Hom.:
15043
Cov.:
32
AF XY:
0.410
AC XY:
30461
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.115
AC:
4791
AN:
41520
American (AMR)
AF:
0.522
AC:
7972
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.380
AC:
1317
AN:
3468
East Asian (EAS)
AF:
0.612
AC:
3158
AN:
5164
South Asian (SAS)
AF:
0.462
AC:
2228
AN:
4820
European-Finnish (FIN)
AF:
0.573
AC:
6034
AN:
10538
Middle Eastern (MID)
AF:
0.452
AC:
133
AN:
294
European-Non Finnish (NFE)
AF:
0.507
AC:
34433
AN:
67964
Other (OTH)
AF:
0.430
AC:
910
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1658
3316
4973
6631
8289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.480
Hom.:
7704
Bravo
AF:
0.390
Asia WGS
AF:
0.512
AC:
1781
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.2
DANN
Benign
0.80
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs592052;
hg19: chr5-78368292;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.